The need for epidemiologic studies of in-situ carcinoma of the breast

Breast Cancer Research and Treatment

Volumn 35, Issue 1, 1995, Pages 65-77

  Millikan, Robert ^a,b   Dressler, Lynn ^a   Geradts, Joseph ^a   Graham, Mark ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

carcinoma in situ; DCIS; epidemiology; etiology; LCIS; precursor lesions; progression

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST LESION; CANCER EPIDEMIOLOGY; CANCER INVASION; CARCINOMA IN SITU; CASE CONTROL STUDY; CELL POPULATION; COHORT ANALYSIS; GENE MUTATION; HUMAN; PRIORITY JOURNAL; STEM CELL; TREATMENT PLANNING;

BREAST NEOPLASMS; CARCINOMA IN SITU; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMAN; RESEARCH; RISK FACTORS;

EID: 0029062412     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF00694747     Document Type: Article

References (79)

1. Breast cancer (part two)
2. Ductal carcinoma in situ of the breast: heterogeneity of individual lesions
3. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice
4. Lobular carcinoma in situ of the female breast: short term results of a prospective study
5. The national cancer data base report on breast cancer
6. Radiographic screening for breast cancer carcinoma: prognostic considerations on the basis of a short-term follow-up
7. Intraductal carcinoma of the breast (1930–69)
8. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
9. Lobular carcinoma in situ: mammographic-pathologic correlation of results of needle-directed biopsy
10. Lobular carcinoma in situ of the breast: mammographic features
11. Noninvasive breast cancer
12. Lobular carcinoma in situ: pathology and treatment
13. Current management of lobular carcinoma in situ of the breast
14. Benign breast diseases, carcinoma in situ, and breast cancer risk
15. Accounting for the multicausal nature of disease in the design and analysis of epidemiologic studies
16. CYPIA1 genetic polymorphisms and in situ colorectal cancer
17. Preventing colon cancer: yet another reason not to smoke
18. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men
19. A genetic model for colorectal tumorigenesis
20. Two molecular pathways to transitional cell carcinoma of the bladder
21. K-RAS and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions
22. Analysis of the p53 gene and its expression in human glioblastoma cells
23. Ras oncogene activation and occupational exposures in acute myeloid leukemia
24. Carcinogens leave fingerprints
25. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis
26. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the etiology of cancer
27. Pattern of p53 gene mutations in breast cancers of women of the midwestern United States
28. Novel pattern of p53 gene mutations in an American black cohort with mortality from breast cancer
29. HER-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones
30. 17 betaestradiol mimics ligand activity of the c-erbB2 protooncogene product
31. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer
32. The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast
33. Increased erbB-2 gene copies and expression in multiple stages of breast cancer
34. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers
35. p53 protein expression in mammary ductal carcinoma in situ
36. Nm23 protein expression in ductal in situ and invasive human breast carcinoma
37. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes
38. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction
39. Value of cytometric analysis for distinction of intraductal carcinoma of the breast
40. Importance of cellular DNA content in premalignant breast disease and pre-invasive carcinoma of the female breast
41. Flow cytometric and histological analysis of ductal carcinoma in situ of the breast
42. Cell kinetics of histologic variants of in situ breast carcinoma
43. Relationship between c-erbB2 immunoreactivity and thymidine labelling index in breast carcinoma in situ
44. Microvessel density and distribution in ductal carcinoma in situ of the breast
45. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells
46. Ductal carcinoma in situ with microinvasion: a curable entity using surgery alone without need for adjuvant therapy
47. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast
48. c-erb-B2 oncogene protein in in-situ and invasive lobular breast neoplasia
49. c-erb-B2 overexpression and histological type of in situ and invasive breast carcinoma
50. Prognostic importance of c-erb-B2 expression in breast cancer
51. Immunohistochemical c-erb-B2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ
52. The DAN profile of breast cancer in situ
53. Cigarette smoking and the risk of breast cancer
54. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue
55. GSTM1 and risk for breast and prostate cancer
56. Alcohol consumption and breast cancer
57. Breast cancer among young U.S. women in relation to oral contraceptive use
58. Blood levels of organochlorine residues and risk of breast cancer
59. Breast cancer and serum organochlorines: a prospective study among white, black, and asian women
60. Organochlorines and breast cancer [letter]
61. Response [letter]
62. Epidemiology of breast cancer
63. Breast cancer among black and white women in the 1980s
64. Racial differences in survival of women with invasive breast cancer in the Detroit metropolitan area
65. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States
66. Breast cancer: magnitude of the problem and descriptive epidemiology
67. Randomized recruitment in case-control studies
68. The design and analysis of case-control studies with biased sampling
69. Borderline epithelial lesions of the breast
70. Mammographically detected breast cancer: nonpalpable is not a synonym for inconsequential
71. Efficient use of biological banks for biochemical epidemiology: exploratory hypothesis testing by means of a sequential t-test
72. Validation of intermediate end points in cancer research
73. Duct carcinoma in situ: pathology and treatment
74. Noninvasive breast carcinoma
75. Histopathology: old principles and new methods
76. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer